SimpleFunctions
Winner-take-all answer·6 source contracts·Kalshi 6·refreshed just now·Closes Jan 1, 2027 · 194d

How many people will Neuralink have implanted in 2026

Leader sits at 88% across 6 bound outcomes, runner-up at 78%. This is a winner-take-all market — the headline is the leader’s price, not an arithmetic mean.

Leader probability

88%

At least 25

runner-up 78¢leader 88¢

Outcomes

6

winner-take-all

Runner-up

78¢

At least 30

Spread

10pp

contested

24h volume

$125

thin orderbook

Closes

Jan 1, 2027

194 days

Venue

Kalshi

6 bound

30-day trend

0%50%100%-30d-3w-2w-1wtodayAt least 25: 88% (23 days, 8 points)At least 25: 88% on 2026-06-15At least 30: 78% (23 days, 10 points)At least 30: 78% on 2026-06-20At least 40: 58% (23 days, 19 points)At least 40: 58% on 2026-06-19
At least 2588¢At least 3078¢At least 4058¢
Top 3 candidates by current price · 23d

Bracket family

How the bracket ladder is priced.

Each row is one outcome on the venue. Sorted by 24h volume — the heaviest book is at the top.

Analysis

Markets are pricing a 90% probability that Neuralink will have implanted at least 25 people by the end of 2026. This reflects confidence in the company's near-term surgical progress, following its first human implant in January 2024. The probability distribution narrows sharply above 25—only a 71% chance of 30+ implants and 32% for 50+—suggesting traders expect measured expansion rather than rapid scaling. Key uncertainties include manufacturing capacity, patient recruitment and screening timelines, and regulatory approval pace for expanded trial sites. The main resolution catalyst will be Neuralink's public disclosures and announcements, likely in quarterly updates or clinical trial communications throughout 2026, which will confirm the actual implant count achieved by year-end.

  • Neuralink's manufacturing capability and ability to produce implants at the rate needed to reach 25+ surgical procedures by December 2026
  • Rate of patient recruitment and medical screening for trial candidates, which constrains how many procedures can be performed
  • Regulatory decisions on expanding trial sites and protocols beyond the current FDA-approved trials
  • No major adverse events or serious complications in existing implant recipients that would halt enrollment
  • Public disclosure frequency and reliability of implant-count reporting throughout 2026

Recently closed in general

These markets stopped trading. Last odds and any captured outcome are shown above — full settlement detail lives at the venue.

More like this

Adjacent prediction questions.

How we compute these odds

SimpleFunctions aggregates live prediction-market contracts from Kalshi and Polymarket. Each slug groups contracts that resolve on the same underlying event, identified by venue event_id.

For binary slugs, the headline probability is the liquidity-weighted mid-price across all bound contracts. For multi-outcome slugs (e.g. elections with 3+ candidates), the headline is the leader’s price; we never arithmetically average disjoint outcomes — that would produce a number with no real-world meaning.

Snapshots refresh every 5 minutes during market hours; daily aggregates are computed at 04:00 UTC. The 30-day sparkline is drawn from per-ticker daily means stored in market_indicator_daily; 24h delta and movement events are derived from the same source.

Last updated on this page: just now.